|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-3-21
|
|
pubmed:abstractText |
To determine expression of cell cycle and apoptotic genes, biochemical analysis of CCL23 and antisense cyclin D1-transfected CCL23 (CCL23AS) cells in the presence of cisplatin was performed. In addition, biochemical analysis of CAL27 cells before and after treatment with cisplatin was performed to determine expression of cell cycle genes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/BCL2L1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase Inhibitor...,
http://linkedlifedata.com/resource/pubmed/chemical/MDM2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Proliferating Cell Nuclear Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-jun,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-mdm2,
http://linkedlifedata.com/resource/pubmed/chemical/Retinoblastoma Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein,
http://linkedlifedata.com/resource/pubmed/chemical/p27 antigen
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0886-4470
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
132
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
317-26
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16549753-Antineoplastic Agents,
pubmed-meshheading:16549753-Apoptosis,
pubmed-meshheading:16549753-Carcinoma, Squamous Cell,
pubmed-meshheading:16549753-Caspase 3,
pubmed-meshheading:16549753-Caspases,
pubmed-meshheading:16549753-Cell Death,
pubmed-meshheading:16549753-Cisplatin,
pubmed-meshheading:16549753-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:16549753-Flow Cytometry,
pubmed-meshheading:16549753-Head and Neck Neoplasms,
pubmed-meshheading:16549753-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:16549753-Proto-Oncogene Proteins c-jun,
pubmed-meshheading:16549753-Proto-Oncogene Proteins c-mdm2,
pubmed-meshheading:16549753-Retinoblastoma Protein,
pubmed-meshheading:16549753-Tumor Cells, Cultured,
pubmed-meshheading:16549753-Tumor Suppressor Protein p53,
pubmed-meshheading:16549753-bcl-X Protein
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
|
|
pubmed:affiliation |
Division of Head and Neck Surgery, University of California, Los Angeles, UCLA David Geffen School of Medicine, 90095-1624, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
